CA2351860A1 - Derives de piperazine ethylamide a activite de recepteur 5-ht1a - Google Patents
Derives de piperazine ethylamide a activite de recepteur 5-ht1a Download PDFInfo
- Publication number
- CA2351860A1 CA2351860A1 CA002351860A CA2351860A CA2351860A1 CA 2351860 A1 CA2351860 A1 CA 2351860A1 CA 002351860 A CA002351860 A CA 002351860A CA 2351860 A CA2351860 A CA 2351860A CA 2351860 A1 CA2351860 A1 CA 2351860A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- disorder
- phenyl
- aryl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21333698A | 1998-12-17 | 1998-12-17 | |
US09/213,336 | 1998-12-17 | ||
PCT/US1999/029953 WO2000035892A1 (fr) | 1998-12-17 | 1999-12-16 | Derives de piperazine ethylamide a activite de recepteur 5-ht1a |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2351860A1 true CA2351860A1 (fr) | 2000-06-22 |
Family
ID=22794714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002351860A Abandoned CA2351860A1 (fr) | 1998-12-17 | 1999-12-16 | Derives de piperazine ethylamide a activite de recepteur 5-ht1a |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1140882A1 (fr) |
JP (1) | JP2002532481A (fr) |
AU (1) | AU3124100A (fr) |
BR (1) | BR9916263A (fr) |
CA (1) | CA2351860A1 (fr) |
WO (1) | WO2000035892A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8106074B2 (en) | 2001-07-13 | 2012-01-31 | Pierre Fabre Medicament | Pyridin-2-yl-methylamine derivatives for treating opiate dependence |
WO2003099266A2 (fr) | 2002-05-23 | 2003-12-04 | Abbott Laboratories | Acetamides et benzamides utilises dans le traitement d'une dysfonction sexuelle |
JP2008526715A (ja) * | 2005-01-03 | 2008-07-24 | ユニベルシタ デグリ ストゥディ ディ シエナ | 神経精神障害の治療のためのアリールピペラジン誘導体 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4895840A (en) * | 1987-06-10 | 1990-01-23 | A. H. Robins Company, Incorporated | N-(aryl-,aryloxy-,arylthio-arylsulfinyl-and arylsulfonyl-)alkyl-N,N'-(or n'n')alkylaminoalkyl ureas and cyanoguanidines |
MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
GB9200293D0 (en) * | 1992-01-08 | 1992-02-26 | Wyeth John & Brother Ltd | Piperazine derivatives |
US5605896A (en) * | 1992-02-25 | 1997-02-25 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities |
WO1995000131A1 (fr) * | 1993-06-23 | 1995-01-05 | Cambridge Neuroscience, Incorporated | Ligands du recepteur sigma et leur utilisation |
CA2307114A1 (fr) * | 1997-10-22 | 1999-04-29 | Clint Duane Walker | Arylpiperazines agissant comme inhibiteurs de la reabsorption de serotonine et comme antagonistes de 5-ht1d.alpha. |
-
1999
- 1999-12-16 WO PCT/US1999/029953 patent/WO2000035892A1/fr not_active Application Discontinuation
- 1999-12-16 EP EP99965292A patent/EP1140882A1/fr not_active Withdrawn
- 1999-12-16 AU AU31241/00A patent/AU3124100A/en not_active Abandoned
- 1999-12-16 CA CA002351860A patent/CA2351860A1/fr not_active Abandoned
- 1999-12-16 BR BR9916263-6A patent/BR9916263A/pt not_active IP Right Cessation
- 1999-12-16 JP JP2000588153A patent/JP2002532481A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1140882A1 (fr) | 2001-10-10 |
JP2002532481A (ja) | 2002-10-02 |
AU3124100A (en) | 2000-07-03 |
BR9916263A (pt) | 2001-09-04 |
WO2000035892A1 (fr) | 2000-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6239126B1 (en) | Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives | |
SK42693A3 (en) | Indoline derivatives with amidic group | |
JP3054677B2 (ja) | 第三級アルキル官能基化ピペラジン誘導体 | |
CA2514612A1 (fr) | Derives de 2,4-diaminopyrimidine utiles en tant qu'inhibiteurs de l'enzyme pkc-theta | |
HRP20030748A2 (en) | Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same | |
JP2013526489A (ja) | 1−[(4−ヒドロキシピペリジン−4−イル)メチル]ピリジン−2(1h)−オン誘導体、その調製方法およびその使用 | |
AU600376B2 (en) | N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy | |
US6242448B1 (en) | Trisubstituted-oxazole derivatives as serotonin ligands | |
JPH04217663A (ja) | 4−アミノメチルピペリジン誘導体 | |
US5486518A (en) | 4-indolylpiperazinyl derivatives | |
US6503928B2 (en) | Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives | |
US6376494B1 (en) | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents | |
US6255302B1 (en) | 1,4-piperazine derivatives | |
CA2351860A1 (fr) | Derives de piperazine ethylamide a activite de recepteur 5-ht1a | |
CA2351400A1 (fr) | Derives d'uree arylpiperidine et aryl-1,2,5,6-tetrahydropyridine presentant une activite de recepteur de 5ht1a | |
US6344458B1 (en) | Piperazine ethylamide derivatives | |
DE60011241T2 (de) | Neue diazol-derivate und ihre verwendung als serotonergische wirkstoffe | |
EP1140830B1 (fr) | Derives d'arylpiperidine et d'aryl-1,2,5,6-tetrahydropyridine amide agissant comme recepteur de 5ht1a | |
AU3123100A (en) | 1,4-piperazine derivatives having 5ht1a receptor activity | |
JP2002538154A (ja) | セロトニン作動活性を有するn−置換イミド誘導体 | |
MXPA01006061A (es) | Derivados de etilamida de piperazina con actividad del receptor 5-ht1a | |
JP2007530658A (ja) | 神経変性障害を治療するためのイソオキサゾール−アミン化合物及びイソチアゾール−アミン化合物 | |
JP2009526844A (ja) | ピペラジン誘導体 | |
MXPA01006065A (en) | 1,4-piperazine derivatives having 5ht1a receptor activity | |
MXPA00010456A (es) | Agentes serotonergicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |